Biohaven股价上涨,陪审团在耶鲁商业秘密案中判赔

路透中文
Jul 28
BUZZ-Biohaven股价上涨,陪审团在耶鲁商业秘密案中判赔

7月27日 - ** Biohaven(BHVN.N)股价上涨3%,至14.74美元

** 该制药公司表示,美国联邦陪审团裁定,Avilar Therapeutics和RA Capital Management (link) 蓄意且恶意窃取了耶鲁大学研发的、与靶向蛋白质降解相关的商业秘密技术

** BHVN已获得耶鲁大学MODA靶向蛋白质降解平台的授权,并持有该技术的开发和商业化权利

** 陪审团还认定RA Capital违反了与耶鲁大学于2019年签署的保密协议

** 裁定因违约向耶鲁大学赔偿200万美元,并因盗用商业秘密分别向耶鲁大学和BHVN各赔偿100万美元

** BHVN和耶鲁大学主张,RA Capital利用该信息协助建立了竞争对手制药公司Avilar

** 2023年3月,在特拉华州联邦地区法院对Avilar和RA Capital提起诉讼

** 截至上一交易日收盘,BHVN今年以来累计上涨30%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10